ArticleFrontiers in oncology2022

Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study.

Darshana Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.